Sangrix Inc. (SGRX)
NASDAQ
0.3880
-0.02 (-4.67%)
Closed
Oct 23, 2026
Day's Range
0.37400.4090
52 wk Range
0.3740126.00
Financial Statements - SGRX - Sangrix Inc.
Revenue
2.88M▼ 53.9%
Net Income
-18.28M▲ 35.2%Net Margin -633.0%
EBITDA
-6.18M▼ 6.2%
Free Cash Flow
-7.92M▼ 15.3%
Income Statement
| Period Ending | 2024-06-30 | 2023-06-30 |
|---|---|---|
| Sales | 2.88M | 6.26M |
| Cost of Goods | 3.83M | 10.82M |
| Gross Profit | -945.20K | -4.56M |
 Operating Expense | - | - |
| Operating Income | -5.96M | -10.82M |
| Non-Operating Interest | - | - |
| Other Income Expense | -10.70M | -16.80M |
| Pre Tax Income | -18.28M | -28.21M |
| Income Tax | 0 | 0 |
| Net Income | -18.28M | -28.21M |
| EPS Basic | -200.4 | -516.599999 |
| EPS Diluted | -200.4 | -516.599999 |
| Basic Shares Outstanding | 87.35K | 54.65K |
| Diluted Shares Outstanding | 87.35K | 54.65K |
| Ebit | -17.78M | -27.98M |
| Ebitda | -6.18M | -5.81M |
| Net Income Continuous Operations | -18.28M | -28.21M |
| Minority Interests | 753.31K | 0 |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
